Skip to main content

Table 2 Model parameter ranges for the sensitivity analysis

From: Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar

Community engagement

Default

Maximum

Minimum

Comments

Number of days spent in a village for CE

1

3

0.5

METF trial

Number of staff in a team

3

8

2

METF trial

Consumables

18

20.7

15.3

+/−15%

Refreshments

19

21.85

16.15

+/−15%

Number of villages provided with a community incentive

3

4

0

Assumption

Cost of community incentives

4828

5000

4103.8

+/−15%

Percentage of villages for CE

5%

10%

0

Assumption

Number of training sessions

4

5

1

Assumption

Number of participants in one training session

10

40

8

Assumption

Number of trainers in one training session

2

3

1

Assumption

Duration of training session

3

5

1

METF trial

Number of trips to a village for community engagement

3

5

1

METF trial

Identification of targeted MDA villages

Default

Maximum

Minimum

Comments

Percentage of villages surveyed to identify hotspot villages

22

25.3

18.7

+/− 15%

Number of days spent in a village for uPCR

1

1.5

0.5

METF trial

Staff involved

4

5

2

METF trial

Incentive for one participant

1

2

0

METF trial

Equipment

5

9.25

4.25

+/−15%

Consumables

1

1.15

0.85

+/− 15%

uPCR analysis cost

25

40

15

METF trial

Number of training sessions

6

7

3

Assumption

Number of participants

20

20

10

Assumption

Number of trainers

2

3

1

Assumption

Duration of training sessions

1

2

0.5

METF trial

Monitoring trip

1

2

0

Assumption

Number of days spent in a village for monitoring

5

10

2

Assumption

Mass treatment

Default

Maximum

Minimum

Comments

Percentage of villages that are offered targeted MDA activity

5%

10%

1%

Assumption

Number of targeted MDA rounds in a year

3

5

1

Assumption

Average percentage of population coverage for targeted MDA in a round

70%

80.5%

59.5%

+/− 15%

Number of days spent in a village for targeted MDA activity

7

9

5

METF trial

Incentive for one participant in a round for targeted MDA

1

2

0

Assumption

Number of trips requiring car rental during targeted MDA activity

15

15

8

METF trial

Equipment cost per village

25

28.75

21.25

+/− 15%

Consumables cost per village

11

12.65

9.35

+/− 15%

Cost of ACT child

0.93

1.0695

0.7905

+/− 15%

Cost of ACT youth

1.46

1.679

1.241

+/−15%

Cost of ACT adult

1.98

2.277

1.683

+/−15%

Cost of primaquine

0.01

0.0115

0.0085

+/− 15%

Cost of medicine for treatment of side-effects per village

39

44.85

33.15

+/− 15%

Antimalarial drug wastage

5

10

3

Assumption

Number of training sessions

5

7

2

Assumption

Number of participants

20

50

15

Assumption

Number of trainers

3

5

2

Assumption

Duration of training sessions

3

5

1

METF trial

Number of monitoring trips

1

3

0

Assumption

Duration of monitoring trips

10

15

5

Assumption

  1. MDA Mass drug administration; uPCR Ultrasensitive polymerase chain reaction; ACT Artemisinin Combination Therapy; METF Malaria Elimination Task Force